3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
35
Plasma cell
33
Other hematologic neoplasm
7
Thoracic
1
Sarcoma
1
Myeloid
1
Dermatologic
1
Conditions
Lymphoma, Large B-Cell, Diffuse
3
Gliosarcoma
3
Glioma
3
Glioblastoma
3
Dendritic Cell Sarcoma, Interdigitating
3
Oligodendroglioma
2
Astrocytoma
2
Sarcoma, Kaposi
1
Recurrence
1
Neuroectodermal Tumors, Primitive
1
Meningioma
1
Lymphoma
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Heart Failure
1
HIV Infections
1
Erdheim-Chester Disease
1
Ependymoma
1
Central Nervous System Neoplasms
1
Cardiotoxicity
1
Brain Neoplasms
1
AIDS-related Kaposi sarcoma
1
Interventions
Cyclophosphamide
39
Peripheral Blood Stem Cell Transplantation
32
fludarabine phosphate
30
Busulfan
26
Filgrastim
24
Cyclosporine
24
Mycophenolic Acid
22
Antilymphocyte Serum
22
Radiotherapy
20
Melphalan
16
Whole-Body Irradiation
15
Tacrolimus
14
Methylprednisolone
14
Methotrexate
13
Cord Blood Stem Cell Transplantation
12
Etoposide
10
sargramostim
5
Thiotepa
5
Temozolomide
5
Sirolimus
5
Rituximab
5
Bevacizumab
5
aldesleukin
4
Therapeutics
4
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Carmustine
4
pembrolizumab
3
Vincristine
3
Topotecan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Lenalidomide
×
Sarcoma
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled